Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-072866)

Filing Details

Accession Number:: 0001104659-23-072866
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-20 16:01:43
Reporting Period:: 2023-06-15

Accepted Time:: 2023-06-20 16:01:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1297184	Amphastar Pharmaceuticals Inc.	AMPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263136	J William Peters	C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730	Cfo, Evp & Treasurer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-15	36,868	$19.79	142,471	No	4	M	Direct
Common Stock	Disposition	2023-06-15	11,868	$48.79	130,603	No	4	S	Direct
Common Stock	Disposition	2023-06-15	12,000	$50.79	118,603	No	4	S	Direct
Common Stock	Disposition	2023-06-15	13,000	$52.79	105,603	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2023-06-15	36,868	$0.00	36,868	$19.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,053		2028-03-15	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022.
Shares subject to the option are fully vested and immediately exercisable.